Tazorac
NDC product · U.S. Food and Drug Administration (openFDA) · United States
-
Product NDC
16110-042 -
Application number
NDA020600 -
SPL ID
6c69ffc2-d34b-467d-a686-989b4135988f -
SPL set ID
4e4e4b81-420e-4492-8a74-80b692a80057 -
UNII
81BDR9Y8PS -
RxCUI
212437 -
RxCUI
212438 -
RxCUI
313199 -
RxCUI
313201
What the source publishes
- Labeler
- Almirall, LLC
- Active ingredients
- tazarotene
- Form
- GEL
- Routes
- CUTANEOUS
- Administrative status
- present-in-source-snapshot
- Marketing status
- NDA
- Product type
- HUMAN PRESCRIPTION DRUG
- Prescription
- Prescription or restricted
Names this record is found by
Complete source data
{
"name": "Tazorac",
"splId": "6c69ffc2-d34b-467d-a686-989b4135988f",
"labels": [
{
"setId": "4e4e4b81-420e-4492-8a74-80b692a80057",
"labelUrl": "https://dailymed.nlm.nih.gov/dailymed/drugInfo.cfm?setid=4e4e4b81-420e-4492-8a74-80b692a80057",
"labelPdfUrl": "https://dailymed.nlm.nih.gov/dailymed/downloadpdffile.cfm?setId=4e4e4b81-420e-4492-8a74-80b692a80057"
}
],
"routes": [
"CUTANEOUS"
],
"labeler": "Almirall, LLC",
"finished": true,
"packaging": [],
"productId": "16110-042_6c69ffc2-d34b-467d-a686-989b4135988f",
"useDomain": "unknown",
"dosageForm": "GEL",
"productNdc": "16110-042",
"deaSchedule": null,
"genericName": "tazarotene",
"productType": "HUMAN PRESCRIPTION DRUG",
"listingStatus": "present-in-source-snapshot",
"targetSpecies": [],
"approvalStatus": "not-established-by-ndc-listing",
"labelAssociation": "openFDA-harmonized-set-ids; not a product-level approval match",
"marketingEndDate": null,
"activeIngredients": [
{
"name": "TAZAROTENE",
"strength": "1 mg/g"
}
],
"applicationNumber": "NDA020600",
"marketingCategory": "NDA",
"stateRestrictions": {
"status": "not-collected",
"observations": []
},
"useDomainEvidence": {
"basis": "unreviewed",
"field": null,
"value": null,
"version": 1,
"sourceId": "us.fda.ndc"
},
"marketingStartDate": "20200221",
"targetSpeciesStatus": "not-reported",
"prescriptionCategory": "prescription-or-restricted",
"harmonizedIdentifiers": {
"nui": [
"N0000175607",
"M0018962"
],
"upc": [
"0316110042107",
"0316110042305",
"0316110833309",
"0316110833101"
],
"unii": [
"81BDR9Y8PS"
],
"rxcui": [
"212437",
"212438",
"313199",
"313201"
],
"spl_set_id": [
"4e4e4b81-420e-4492-8a74-80b692a80057"
],
"pharm_class_cs": [
"Retinoids [CS]"
],
"pharm_class_epc": [
"Retinoid [EPC]"
],
"manufacturer_name": [
"Almirall, LLC"
],
"is_original_packager": [
true
]
},
"listingExpirationDate": "20271231"
}
Read this record from your own software
The same record, with every field and its provenance, is one request away. An API key is free and works immediately.
curl -G "https://api.medifontis.com/v1/drugs/record" \
-H "Authorization: Bearer $MEDIFONTIS_API_KEY" \
--data-urlencode "country=us" \
--data-urlencode "sourceId=us.fda.ndc" \
--data-urlencode "id=us:fda:ndc:16110-042_6c69ffc2-d34b-467d-a686-989b4135988f"